Rafferty Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Rafferty Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-217,928	Closed	-$8.57M	–	1117
2023 Q2	$8.57M	Sell	217,928 -97,540	-31%	-$3.44M	0.05%	244
2023 Q1	$7.68M	Sell	315,468 -82,888	-21%	-$1.81M	0.05%	255
2022 Q4	$8.53M	Buy	398,356 +25,594	+7%	+$546K	0.07%	233
2022 Q3	$6.69M	Buy	372,762 +22,146	+6%	+$291K	0.07%	238
2022 Q2	$3.37M	Buy	350,616 +24,302	+7%	+$305K	0.03%	366
2022 Q1	$5.49M	Sell	326,314 -35,115	-10%	-$519K	0.03%	366
2021 Q4	$6.04M	Buy	361,429 +190,515	+111%	+$3.12M	0.03%	300
2021 Q3	$2.78M	Buy	170,914 +75,543	+79%	+$822K	0.02%	524
2021 Q2	$602K	Sell	95,371 -62,296	-40%	-$402K	﹤0.01%	1036
2021 Q1	$974K	Buy	157,667 +127,578	+424%	+$774K	0.01%	777
2020 Q4	$208K	Buy	+30,089	New	+$193K	﹤0.01%	982

Rafferty Asset Management's ISEE Position: Q3 2023 in Review

Rafferty Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 217,928 shares — an estimated $8.57M sold.

Rafferty Asset Management first reported a position in ISEE in Q4 2020 and held it in 11 quarters. The position peaked at $8.57M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Rafferty Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Rafferty Asset Management sold 217,928 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $8.57M.
Rafferty Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Rafferty Asset Management's IVERIC bio, Inc. Common Stock position peaked at $8.57M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Rafferty Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.